melatonin and methylphenidate

melatonin has been researched along with methylphenidate in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (35.71)29.6817
2010's7 (50.00)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Kerbl, R; Kurz, R; Millner, M; Zotter, H1
Appenrodt, E; Schwarzberg, H1
A Versteegh, FG; Broeren, JPA; Starreveld, JS; Tjon Pian Gi, CV1
Barton, R1
Lahti, TA; Partonen, T1
Bateman, N; Bond, C; Helms, PJ; Lee, AJ; McCaig, D; McLay, J; Stewart, D; Tobaiqy, M1
Augustin-Morales, MD; Contreras-Chova, F; Cubero-Millán, I; Justicia-Martínez, F; Khaldy-Belkadi, H; Molina-Carballo, A; Muñoz-Hoyos, A; Naranjo-Gómez, A; Ruiz-Ramos, MJ; Uberos, J1
Cubero-Millán, I; Fernández-López, L; Luna-del-Castillo, JD; Machado-Casas, I; Martínez-Serrano, S; Molina-Carballo, A; Muñoz-Hoyos, A; Ruiz-López, A; Tortosa-Pinto, P; Uberos, J1
Charman, T; Findon, JL; Howes, OD; King, BH; Loth, E; McAlonan, GM; McCracken, JT; Murphy, DG; Parr, JR; Povey, C; Rogdaki, M; Santosh, P; Simonoff, E; Wallace, S; Wichers, RH1
Anagnostou, E1
Balachandran, D; Bruera, E; Carmack, C; Delgado, M; Eng, C; Guzman Gutierrez, D; Hess, KR; Lim, B; Lu, Z; Ochoa, J; Park, M; Raznahan, M; Williams, JL; Yennurajalingam, S1
Checa-Ros, A; D'Marco, L; Molina-Carballo, A; Muñoz-Hoyos, A; Ouadih-Moran, M; Seiquer, I1

Reviews

3 review(s) available for melatonin and methylphenidate

ArticleYear
Use of medication in children with psychiatric disorders.
    Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association, 2007, Volume: 80, Issue:11

    Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom

2007
Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.
    Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:1

    Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Brain; Consensus; Guanfacine; Humans; Melatonin; Methylphenidate; Psychopharmacology; Sleep Wake Disorders

2018
Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
    Current opinion in neurology, 2018, Volume: 31, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Depressants; Central Nervous System Stimulants; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Irritable Mood; Melatonin; Metformin; Methylphenidate; Obesity; Outcome Assessment, Health Care; Precision Medicine; Risperidone; Sleep; Sleep Wake Disorders

2018

Trials

3 trial(s) available for melatonin and methylphenidate

ArticleYear
Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study.
    European journal of pediatrics, 2003, Volume: 162, Issue:7-8

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Depressants; Central Nervous System Stimulants; Child; Circadian Rhythm; Humans; Melatonin; Methylphenidate; Sleep; Sleep Initiation and Maintenance Disorders

2003
Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes.
    International journal of molecular sciences, 2014, Sep-25, Volume: 15, Issue:9

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Circadian Rhythm; Conduct Disorder; Depression; Female; Homeostasis; Humans; Impulsive Behavior; Male; Melatonin; Methylphenidate; Personality Inventory; Sleep Disorders, Intrinsic

2014
Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs.
    Nutrients, 2023, Jan-31, Volume: 15, Issue:3

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Fatty Acids, Omega-3; Humans; Melatonin; Methylphenidate; S100 Calcium Binding Protein beta Subunit; Treatment Outcome

2023

Other Studies

8 other study(ies) available for melatonin and methylphenidate

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Methylphenidate and melatonin for sleep disorder with optic glioma.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:9

    Topics: Anticonvulsants; Child; Circadian Rhythm; Dopamine Agents; Drug Therapy, Combination; Humans; Male; Melatonin; Methylphenidate; Optic Nerve Glioma; Sleep Wake Disorders

2001
Methylphenidate-induced motor activity in rats: modulation by melatonin and vasopressin.
    Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antioxidants; Arginine Vasopressin; Central Nervous System Stimulants; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Melatonin; Methylphenidate; Motor Activity; Pineal Gland; Rats; Rats, Wistar; Vasopressins

2003
CREM mutations and ADHD symptoms.
    Medical hypotheses, 2009, Volume: 72, Issue:5

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Cyclic AMP Response Element Modulator; Humans; Melatonin; Methylphenidate; Mice; Mice, Knockout; Mutation

2009
A pilot study to evaluate a community pharmacy-based monitoring system to identify adverse drug reactions associated with paediatric medicines use.
    European journal of clinical pharmacology, 2010, Volume: 66, Issue:6

    Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Anticonvulsants; Atomoxetine Hydrochloride; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Infant; Infant, Newborn; Melatonin; Methylphenidate; Pharmacies; Pilot Projects; Propylamines; Prospective Studies; Sample Size; Scotland; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires

2010
Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD.
    Journal of psychiatric research, 2013, Volume: 47, Issue:3

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Body Height; Body Mass Index; Body Weight; Central Nervous System Stimulants; Child; Child, Preschool; Circadian Rhythm; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Melatonin; Methylphenidate; Psychiatric Status Rating Scales; Radioimmunoassay; Retrospective Studies; Serotonin

2013
Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy.
    BMJ supportive & palliative care, 2021, Volume: 11, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Stimulants; Combined Modality Therapy; Double-Blind Method; Feasibility Studies; Female; Humans; Male; Melatonin; Methylphenidate; Middle Aged; Neoplasms; Phototherapy; Sleep; Sleep Initiation and Maintenance Disorders

2021